AbCellera Biologics Inc (NASDAQ: ABCL) is -13.31% lower on its value in year-to-date trading and has touched a low of $2.11 and a high of $4.83 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ABCL stock was last observed hovering at around $2.52 in the last trading session, with the day’s gains setting it 0.02%.
Currently trading at $2.54, the stock is -4.77% and -14.23% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.11 million and changing 0.79% at the moment leaves the stock -12.03% off its SMA200. ABCL registered -48.27% loss for a year compared to 6-month gain of -5.22%. The firm has a 50-day simple moving average (SMA 50) of $2.9615 and a 200-day simple moving average (SMA200) of $2.8874.
The stock witnessed a -19.11% loss in the last 1 month and extending the period to 3 months gives it a -12.71%, and is 15.45% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.42% over the week and 7.44% over the month.
AbCellera Biologics Inc (ABCL) has around 596 employees, a market worth around $756.89M and $28.83M in sales. Profit margin for the company is -564.81%. Distance from 52-week low is 20.38% and -47.41% from its 52-week high. The company has generated returns on investments over the last 12 months (-14.58%).
The EPS is expected to shrink by -10.53% this year.
AbCellera Biologics Inc (ABCL) Top Institutional Holders
200.0 institutions hold shares in AbCellera Biologics Inc (ABCL), with institutional investors hold 55.07% of the company’s shares. The shares outstanding are 295.76M, and float is at 223.58M with Short Float at 8.90%. Institutions hold 42.47% of the Float.
The top institutional shareholder in the company is BAKER BROS. ADVISORS LP with over 27.53 million shares valued at $81.48 million. The investor’s holdings represent 9.3556% of the ABCL Shares outstanding. As of 2024-06-30, the second largest holder is BAILLIE GIFFORD & CO with 21.91 million shares valued at $64.86 million to account for 7.4472 of the shares outstanding. The other top investors are VOYA INVESTMENT MANAGEMENT LLC which holds 10.62 million shares representing 3.611% and valued at over $31.45 million, while CAPITAL WORLD INVESTORS holds 1.8078 of the shares totaling 5.32 million with a market value of $15.74 million.
AbCellera Biologics Inc (ABCL) Insider Activity
#####
